GlaxoSmithKline Pharmaceuticals Ltd — Quarterly Results & Earnings

₹2283.00

-3.43%

Profit Growth YoY2.57%Latest quarter

Sales Growth YoY-3.05%Latest quarter

Sales CAGR 5Y3.06%5 year compound

Profit CAGR 5Y34.71%5 year compound

📋

Quarterly Performance

YoY Profit Growth+2.57%

📈 Moderate growth

YoY Sales Growth-3.05%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

25.52%

EPS Growth 5Y

34.71%

Interest Coverage

Higher = safer debt servicing

811.63

ROE

46.87%

ROCE

63.25%

💡

Growth Analysis

GlaxoSmithKline Pharmaceuticals Ltd reported YoY profit growth of 2.57% and revenue growth of -3.05% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 3.06% and profits at 34.71% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on GlaxoSmithKline Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.